HIF1A and nonpapillary renal cell carcinoma: Together, these data implicate HIF1α in mediating alterations in kidney metabolism that drive tumorigenesis, and suggest that TRACK mice represent a valid model to test therapies that target metabolism with the goal of inhibiting ccRCC.